Back to top
more

Insulet (PODD)

(Delayed Data from NSDQ)

$322.22 USD

322.22
1,102,803

-9.91 (-2.98%)

Updated Sep 17, 2025 04:00 PM ET

After-Market: $321.30 -0.92 (-0.29%) 5:16 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (87 out of 245)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

DexCom (DXCM) Partners With RxFood for Automated Dietary Monitoring

by Zacks Equity Research

DexCom's (DXCM) CGM systems will make dietary assessment through AI-enabled RxFood app, which automatically interprets food images for calorie count in Canada.

Zacks Equity Research

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

Here's Why You Should Retain Insulet (PODD) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Insulet (PODD) on the strength of the Omnipod 5 AID system.

Zacks Equity Research

Insulet (PODD) Expands Omnipod 5 Even As Macro Woes Linger

by Zacks Equity Research

Insulet's (PODD) international expansion efforts are aligned with its long-term growth profile.

Zacks Equity Research

Zacks Investment Ideas feature highlights: Workday, Energy Transfer and Insulet

by Zacks Equity Research

Workday, Energy Transfer and Insulet are part of the Zacks Investment Ideas article.

Derek Lewis headshot

Insider Buys: 3 CEOs Scooping Up Shares

by Derek Lewis

These 3 CEOs have put their money where their mouths are, recently stepping up and acquiring shares. Given their confidence, should investors follow them into their trades?

Zacks Equity Research

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Insulet (PODD) Launches Omnipod 5 AID System in Germany

by Zacks Equity Research

Insulet's (PODD) Omnipod 5 is available in the United States and the United Kingdom.

Zacks Equity Research

MDT or PODD: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

MDT vs. PODD: Which Stock Is the Better Value Option?

Zacks Equity Research

Insulet (PODD) Q2 Earnings Beat, Sales Growth View Raised

by Zacks Equity Research

Insulet's (PODD) Omnipod 5 gains market share in the second quarter within the diabetes technology market as the only FDA-approved fully disposable, pod-based automated insulin delivery system.

Zacks Equity Research

Here's What Key Metrics Tell Us About Insulet (PODD) Q2 Earnings

by Zacks Equity Research

The headline numbers for Insulet (PODD) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Equity Research

Insulet (PODD) Tops Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Insulet (PODD) delivered earnings and revenue surprises of 58.33% and 3.26%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Here's Why You Should Retain Insulet (PODD) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Insulet (PODD) on the strength of the Omnipod 5 AID system.

Zacks Equity Research

Minerva Surgical, Inc. (UTRS) Reports Q2 Loss, Misses Revenue Estimates

by Zacks Equity Research

Minerva Surgical, Inc. (UTRS) delivered earnings and revenue surprises of 44.44% and 3.80%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

ZBH or PODD: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ZBH vs. PODD: Which Stock Is the Better Value Option?

Zacks Equity Research

Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for FXH

Zacks Equity Research

Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?

by Zacks Equity Research

Sector ETF report for FXH

Zacks Equity Research

ESLOY vs. PODD: Which Stock Is the Better Value Option?

by Zacks Equity Research

ESLOY vs. PODD: Which Stock Is the Better Value Option?

Zacks Equity Research

Here's Why You Should Retain Insulet (PODD) Stock for Now

by Zacks Equity Research

Investors are optimistic about Insulet (PODD) owing to strength in Omnipod 5 and its focus on market expansion.

Zacks Equity Research

Insulet (PODD) Launches the Omnipod 5 AID System in the UK

by Zacks Equity Research

Insulet (PODD) commercializes its revolutionary Omnipod 5 AID System in the United Kingdom.

Zacks Equity Research

ESLOY or PODD: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ESLOY vs. PODD: Which Stock Is the Better Value Option?

Zacks Equity Research

Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RYH)?

by Zacks Equity Research

Sector ETF report for RYH

Zacks Equity Research

Is Invesco S&P 500 Equal Weight Health Care ETF (RYH) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for RYH

Zacks Equity Research

Here's Why You Should Retain Insulet (PODD) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Insulet (PODD) on the robust performance of Omnipod 5.

Zacks Equity Research

HAE or PODD: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

HAE vs. PODD: Which Stock Is the Better Value Option?